| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| YA II PN, Ltd. | 9.9% | $559,595 | 508,723 | YA II PN, Ltd. | 19 Dec 2025 | |||
| Alumni Capital LP | 10% | $801,687 | 369,373 | Alumni Capital LP | 20 Jun 2025 |
As of 30 Sep 2025, 13 institutional investors reported holding 23,584 shares of RedHill Biopharma Ltd. - American Depositary Shares (RDHL). This represents 0.46% of the company’s total 5,138,616 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 4,828 | $4,973 | +$4,834 | $1.03 | 1 |
| 2025 Q3 | 23,584 | $51,175 | +$9,088 | $2.17 | 13 |
| 2025 Q2 | 19,540 | $37,852 | -$36,277 | $1.94 | 11 |
| 2025 Q1 | 30,251 | $80,464 | +$34,765 | $2.66 | 11 |
| 2024 Q4 | 16,679 | $103,485 | +$68,875 | $6.17 | 10 |
| 2024 Q3 | 5,579 | $48,750 | +$48,750 | $8.73 | 8 |